UK markets open in 43 minutes
  • NIKKEI 225

    27,885.87
    +65.47 (+0.24%)
     
  • HANG SENG

    19,308.58
    -209.71 (-1.07%)
     
  • CRUDE OIL

    77.47
    +0.54 (+0.70%)
     
  • GOLD FUTURES

    1,780.60
    -0.70 (-0.04%)
     
  • DOW

    33,947.10
    -482.78 (-1.40%)
     
  • BTC-GBP

    13,962.21
    -307.28 (-2.15%)
     
  • CMC Crypto 200

    401.66
    -9.55 (-2.32%)
     
  • ^IXIC

    11,239.94
    -221.56 (-1.93%)
     
  • ^FTAS

    4,143.21
    +4.40 (+0.11%)
     

Bioventix Plc - Director Dealing

Bioventix plc

(“Bioventix” or “the Company”)

Director Dealing

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that it has been notified that Bruce Hiscock, Chief Financial Officer of the Company, completed the following dealings in the Company’s ordinary shares of 5 pence in the Company ("Ordinary Shares"):

  • the transfer, via sale and purchase, of 204 Ordinary Shares into his ISA. Mr Hiscock sold 204 Ordinary Shares at a price of £33.41 from an account in his own name and bought 204 Ordinary Shares at a price of £34.00 to be held in his ISA; and

  • the additional purchase of 276 Ordinary Shares at a price of £34.00 into his ISA.

Following these transactions, Mr Hiscock’s total beneficial interest in the Company is now 700 Ordinary Shares, representing approximately 0.01 per cent. of the Company’s total issued share capital.

For further information please contact:

Bioventix plc
Peter Harrison


Chief Executive Officer

Tel: 01252 728 001

finnCap Ltd
Geoff Nash/Simon Hicks/Abigail Kelly
Alice Lane


Corporate Finance
ECM

Tel: 020 7220 0500

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bruce Hiscock

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bioventix plc

b)

LEI

213800225MHX7LZQY108

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares

Identification code

GB00B4QVDF07

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Volume(s)

Prices (pence)

204

3,341

d)

Aggregated information:
·Aggregated volume
·Price

Sale of 204 Ordinary Shares at a price of 3,341p per Ordinary Share

e)

Date of the transaction

26 October 2022

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bruce Hiscock

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bioventix plc

b)

LEI

213800225MHX7LZQY108

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares

Identification code

GB00B4QVDF07

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Volume(s)

Prices (pence)

480

3,400

d)

Aggregated information:
·Aggregated volume
·Price

Purchase of 480 Ordinary Shares at a price of 3,400p per Ordinary Share

e)

Date of the transaction

26 October 2022

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)